vs
MERIT MEDICAL SYSTEMS INC（MMSI）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
MERIT MEDICAL SYSTEMS INC的季度营收约是ROGERS CORP的1.9倍（$381.9M vs $200.5M），MERIT MEDICAL SYSTEMS INC净利率更高（10.7% vs 2.2%，领先8.5%），MERIT MEDICAL SYSTEMS INC同比增速更快（7.5% vs 5.2%），MERIT MEDICAL SYSTEMS INC自由现金流更多（$24.7M vs $1.1M），过去两年MERIT MEDICAL SYSTEMS INC的营收复合增速更高（6.3% vs -3.3%）
梅里特医疗系统公司是一家全球性医疗设备企业，设计、生产和销售适用于心脏病学、放射学、肿瘤学、内窥镜及重症监护领域的介入和诊断产品，为全球医院及医疗机构提供微创医疗解决方案，助力提升患者疗效和临床操作效率。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
MMSI vs ROG — 直观对比
营收规模更大
MMSI
是对方的1.9倍
$200.5M
营收增速更快
MMSI
高出2.2%
5.2%
净利率更高
MMSI
高出8.5%
2.2%
自由现金流更多
MMSI
多$23.6M
$1.1M
两年增速更快
MMSI
近两年复合增速
-3.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $381.9M | $200.5M |
| 净利润 | $41.0M | $4.5M |
| 毛利率 | 48.4% | 32.2% |
| 营业利润率 | 11.6% | — |
| 净利率 | 10.7% | 2.2% |
| 营收同比 | 7.5% | 5.2% |
| 净利润同比 | 36.0% | 421.4% |
| 每股收益（稀释后） | $0.68 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MMSIROG
| Q1 26 | $381.9M | $200.5M | ||
| Q4 25 | $393.9M | $201.5M | ||
| Q3 25 | $384.2M | $216.0M | ||
| Q2 25 | $382.5M | $202.8M | ||
| Q1 25 | $355.4M | $190.5M | ||
| Q4 24 | $355.2M | $192.2M | ||
| Q3 24 | $339.8M | $210.3M | ||
| Q2 24 | $338.0M | $214.2M |
净利润MMSIROG
| Q1 26 | $41.0M | $4.5M | ||
| Q4 25 | $38.0M | $4.6M | ||
| Q3 25 | $27.8M | $8.6M | ||
| Q2 25 | $32.6M | $-73.6M | ||
| Q1 25 | $30.1M | $-1.4M | ||
| Q4 24 | $27.9M | $-500.0K | ||
| Q3 24 | $28.4M | $10.7M | ||
| Q2 24 | $35.7M | $8.1M |
毛利率MMSIROG
| Q1 26 | 48.4% | 32.2% | ||
| Q4 25 | 49.6% | 31.5% | ||
| Q3 25 | 48.5% | 33.5% | ||
| Q2 25 | 48.2% | 31.6% | ||
| Q1 25 | 48.4% | 29.9% | ||
| Q4 24 | 48.7% | 32.1% | ||
| Q3 24 | 46.4% | 35.2% | ||
| Q2 24 | 47.7% | 34.1% |
营业利润率MMSIROG
| Q1 26 | 11.6% | — | ||
| Q4 25 | 13.8% | 3.5% | ||
| Q3 25 | 11.1% | 7.3% | ||
| Q2 25 | 12.3% | -33.3% | ||
| Q1 25 | 11.5% | -0.2% | ||
| Q4 24 | 10.3% | -6.6% | ||
| Q3 24 | 11.0% | 6.9% | ||
| Q2 24 | 13.6% | 5.3% |
净利率MMSIROG
| Q1 26 | 10.7% | 2.2% | ||
| Q4 25 | 9.6% | 2.3% | ||
| Q3 25 | 7.2% | 4.0% | ||
| Q2 25 | 8.5% | -36.3% | ||
| Q1 25 | 8.5% | -0.7% | ||
| Q4 24 | 7.9% | -0.3% | ||
| Q3 24 | 8.4% | 5.1% | ||
| Q2 24 | 10.6% | 3.8% |
每股收益（稀释后）MMSIROG
| Q1 26 | $0.68 | $0.25 | ||
| Q4 25 | $0.64 | $0.20 | ||
| Q3 25 | $0.46 | $0.48 | ||
| Q2 25 | $0.54 | $-4.00 | ||
| Q1 25 | $0.49 | $-0.08 | ||
| Q4 24 | $0.46 | $-0.04 | ||
| Q3 24 | $0.48 | $0.58 | ||
| Q2 24 | $0.61 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $488.1M | $195.8M |
| 总债务越低越好 | $735.2M | — |
| 股东权益账面价值 | $1.6B | $1.2B |
| 总资产 | $2.7B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.45× | — |
8季度趋势，按日历期对齐
现金及短期投资MMSIROG
| Q1 26 | $488.1M | $195.8M | ||
| Q4 25 | $446.4M | $197.0M | ||
| Q3 25 | $392.5M | $167.8M | ||
| Q2 25 | $341.8M | $157.2M | ||
| Q1 25 | $395.5M | $175.6M | ||
| Q4 24 | $376.7M | $159.8M | ||
| Q3 24 | $523.1M | $146.4M | ||
| Q2 24 | $636.7M | $119.9M |
总债务MMSIROG
| Q1 26 | $735.2M | — | ||
| Q4 25 | $734.0M | — | ||
| Q3 25 | $732.9M | — | ||
| Q2 25 | $731.8M | — | ||
| Q1 25 | $730.7M | — | ||
| Q4 24 | $729.6M | — | ||
| Q3 24 | $750.5M | — | ||
| Q2 24 | $801.3M | — |
股东权益MMSIROG
| Q1 26 | $1.6B | $1.2B | ||
| Q4 25 | $1.6B | $1.2B | ||
| Q3 25 | $1.5B | $1.2B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.4B | $1.3B | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.3B | $1.3B | ||
| Q2 24 | $1.3B | $1.3B |
总资产MMSIROG
| Q1 26 | $2.7B | $1.4B | ||
| Q4 25 | $2.7B | $1.4B | ||
| Q3 25 | $2.6B | $1.4B | ||
| Q2 25 | $2.6B | $1.5B | ||
| Q1 25 | $2.5B | $1.5B | ||
| Q4 24 | $2.4B | $1.5B | ||
| Q3 24 | $2.4B | $1.5B | ||
| Q2 24 | $2.4B | $1.5B |
负债/权益比MMSIROG
| Q1 26 | 0.45× | — | ||
| Q4 25 | 0.46× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.49× | — | ||
| Q1 25 | 0.51× | — | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 0.57× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $24.7M | $1.1M |
| 自由现金流率自由现金流/营收 | 6.5% | 0.5% |
| 资本支出强度资本支出/营收 | 4.2% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 1.29× |
| 过去12个月自由现金流最近4个季度 | $220.8M | $70.1M |
8季度趋势，按日历期对齐
经营现金流MMSIROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $98.5M | $46.9M | ||
| Q3 25 | $75.0M | $28.9M | ||
| Q2 25 | $83.3M | $13.7M | ||
| Q1 25 | $40.6M | $11.7M | ||
| Q4 24 | $68.7M | $33.7M | ||
| Q3 24 | $47.3M | $42.4M | ||
| Q2 24 | $68.5M | $22.9M |
自由现金流MMSIROG
| Q1 26 | $24.7M | $1.1M | ||
| Q4 25 | $74.0M | $42.2M | ||
| Q3 25 | $52.5M | $21.2M | ||
| Q2 25 | $69.6M | $5.6M | ||
| Q1 25 | $19.5M | $2.1M | ||
| Q4 24 | $65.3M | $18.3M | ||
| Q3 24 | $38.0M | $25.2M | ||
| Q2 24 | $57.9M | $8.8M |
自由现金流率MMSIROG
| Q1 26 | 6.5% | 0.5% | ||
| Q4 25 | 18.8% | 20.9% | ||
| Q3 25 | 13.7% | 9.8% | ||
| Q2 25 | 18.2% | 2.8% | ||
| Q1 25 | 5.5% | 1.1% | ||
| Q4 24 | 18.4% | 9.5% | ||
| Q3 24 | 11.2% | 12.0% | ||
| Q2 24 | 17.1% | 4.1% |
资本支出强度MMSIROG
| Q1 26 | 4.2% | 2.3% | ||
| Q4 25 | 6.2% | 2.3% | ||
| Q3 25 | 5.8% | 3.6% | ||
| Q2 25 | 3.6% | 4.0% | ||
| Q1 25 | 5.9% | 5.0% | ||
| Q4 24 | 1.0% | 8.0% | ||
| Q3 24 | 2.8% | 8.2% | ||
| Q2 24 | 3.1% | 6.6% |
现金转化率MMSIROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | 2.59× | 10.20× | ||
| Q3 25 | 2.70× | 3.36× | ||
| Q2 25 | 2.56× | — | ||
| Q1 25 | 1.35× | — | ||
| Q4 24 | 2.46× | — | ||
| Q3 24 | 1.66× | 3.96× | ||
| Q2 24 | 1.92× | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
